CD274 and cancer: Meta-analyses on different cancer sites have shown that PD-L1 is a biomarker of poor prognosis in cervical, breast, endometrial, pancreatic, and colorectal cancer, but not in ovarian cancer [14,16,47,49,50,62,63,64].